Algeria, Cuba to boost health, biotechnology cooperation
ALGERIA: Algeria and Cuba have signed an agreement to extend a
treatment program for diabetic foot and a Memorandum of Understanding
aimed at creating a bi-national biotechnological center.
Algeria’s Health Secretary General Shakou, and the Director of the
Centre for Genetic Engineering and Biotechnology in Cuba (CIGB), Luis
Herrera, signed the documents that will strengthen the bilateral
cooperation in health and biotechnology development.
The Cuban Embassy in Algiers noted that the agreement establishes the
implementation of a pilot program aimed at the application throughout
Algeria of the diabetic foot treatment with Heberprot medications, which
were developed at CIGB.
This will benefit thousands of patients with the disease in the
Maghreb and it will avoid a 92 percent lower limb amputations, official
sources explained.
Also, the MoU lies the foundations for the creation of an institution
that will allow Algeria to be inserted in the future in the small group
of countries with their own capacity to implement the most advanced
medicine in biotechnology.
Algiers, Prensa Latina
|